WHAT YOU NEED TO KNOW CAPA Files Amicus Brief Urging the Supreme Court to Preserve IPR to Lower Drug Prices. DID YOU KNOW – The U.S. Supreme Court is reviewing Arthrex Inc. v. Smith & Nephew Inc. to determine the constitutionality of the Patent Trial and Appeal Board (PTAB). In an amicus brief filed recently, CAPA outlined […]

Continue Reading

Patients Face Rising Costs for Critical Medications to Treat COVID-19 Related Effects WASHINGTON D.C. – Even before the COVID-19 pandemic, more than 58 million Americans struggled to afford their prescription drugs.  Now, the economic impact of the health crisis continues to leave millions of American workers, families and seniors struggling just to stay afloat.  Meanwhile, a new report released by Patients For […]

Continue Reading

WASHINGTON D.C. – As millions of Americans continue to grapple with high drug prices, a case before the U.S. Supreme Court surrounding the constitutionality of the Patent Trial and Appeal Board (PTAB) has taken on national significance for this growing national problem.  That’s why the Coalition Against Patent Abuse (CAPA) last week filed an amicus brief with […]

Continue Reading

WHAT YOU NEED TO KNOW CAPA: The USPTO must prioritize patent quality and restore the IPR system to its proper focus. UPDATE – As part of its ongoing campaign to safeguard the U.S. patent system and stop Big Pharma from gaming the system, CAPA filed comments this week with the United States Patent and Trademark Office (USPTO).  The […]

Continue Reading

WASHINGTON D.C. – As part of its ongoing campaign to safeguard the U.S. patent system and stop Big Pharma from gaming the system, the Coalition Against Patent Abuse (CAPA) this week filed comments with the United States Patent and Trademark Office (USPTO) outlining its concerns regarding the increased use of discretionary denials by the Patent Trial and Appeal […]

Continue Reading